# US 2015/0021339 A1 · PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0021339 A1
- Document ID: US20150021339A1
- Status: Published application
- Kind: A1
- Application number: 14/357,418
- Filed: 2012-11-09
- Published: 2015-01-22
- Earliest claimed: 2011-11-11
- Assignees: Sio2 Medical Products, Inc.
- Inventors: John T. Felts; Thomas E. Fisk; Robert S. Abrams; John Ferguson; Jonathan R. Freedman; Robert J. Pangborn; Peter J. Sagona; Christopher Weikart
- Web page: https://patentgrep.com/patent/US20150021339A1

## CPC

- B65D 25/14: Linings or internal coatings (of containers made by folding or erecting blanks made of paper B65D5/56 {; linings for domestic water storage heaters F24H1/183})
- A61M 5/3129: {Syringe barrels (A61M5/3205, A61M5/50 take precedence)}
- B65D 25/04: Partitions
- C23C 16/045: {Coating cavities or hollow spaces, e.g. interior of tubes; Infiltration of porous substrates}
- C23C 16/30: Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
- C23C 16/36: Carbonitrides
- C23C 16/401: {containing silicon}
- C23C 16/507: using external electrodes, e.g. in tunnel type reactors
- A61J 1/05: for collecting, storing or administering blood, plasma or medical fluids {(multiple bags systems for separating or storing blood components A61M1/0209); Infusion or perfusion containers}
- A61M 2005/3109: {Caps sealing the needle bore by use of, e.g. air-hardening adhesive, elastomer or epoxy resin}
- A61M 2005/3131: {specially adapted for improving sealing or sliding}
- B65D: CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- C23C: COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL (making metal-coated products by extrusion B21C23/22; covering with metal by connecting pre-existing layers to articles, see the relevant places, e.g. B21D39/00, B23K; metallising of glass C03C; metallising mortars, concrete, artificial stone, ceramics or natural stone C04B41/00; enamelling of, or applying a vitreous layer to, metals C23D; treating metal surfaces or coating of metals by electrolysis or electrophoresis C25D; single-crystal film growth C30B; by metallising textiles D06M11/83; decorating textiles by locally metallising D06Q1/04)
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE

## Abstract

A method for providing a passivation layer or pH protective coating on a substrate surface by PECVD is provided, the method comprising generating a plasma from a gaseous reactant comprising polymerizing gases. The lubricity, passivation, pH protective, hydrophobicity, and/or barrier properties of the passivation layer or pH protective coating are set by setting the ratio of the O2 to the organosilicon precursor in the precursor feed, and/or by setting the electric power used for generating the plasma. In particular, a passivation layer or pH protective coating made by the method is provided. Pharmaceutical packages coated by the method and the use of such packages protecting a composition contained in the vessel against mechanical and/or chemical effects of the surface of the package without a passivation layer or pH protective coating material are also provided.

## Claims

### Claim 1

A filled package comprising:
a vessel having a lumen defined at least in part by a wall, the wall having an interior surface facing the lumen and an outer surface;
a barrier coating or layer of SiOx, wherein x is from 1.5 to 2.9, from 2 to 1000 nm thick, the barrier coating or layer of SiOx having an interior surface facing the lumen and an outer surface facing the wall interior surface, the barrier coating or layer being effective to reduce the ingress of atmospheric gas into the lumen compared to an vessel without a barrier coating or layer;
a passivation layer or pH protective coating of SiOxCy or SiNxCy wherein x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3, the passivation layer or pH protective coating having an interior surface facing the lumen and an outer surface facing the interior surface of the barrier coating or layer, the passivation layer or pH protective coating being effective to increase the calculated shelf life of the package (total Si/Si dissolution rate); and
a fluid composition contained in the lumen and having a pH between 4 and 10;
wherein the calculated shelf life of the package is more than six months at a storage temperature of 4° C.

### Claim 2

(canceled)

### Claim 3

An article comprising:
a wall having a surface;
a barrier coating or layer of SiOx, wherein x is from 1.5 to 2.9, from 2 to 1000 nm thick, the barrier coating or layer of SiOx, having an interior surface facing the lumen and an outer surface facing the wall interior surface, the barrier coating or layer being effective to reduce the ingress of atmospheric gas through the wall compared to an uncoated wall; and
a passivation layer or pH protective coating of SiOxCy or SiNxCy wherein x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3, on the barrier coating or layer, the passivation layer or pH protective coating being formed by chemical vapor deposition of a precursor selected from a a linear siloxane, a monocyclic siloxane, a polycyclic siloxane, a polysilsesquioxane, a linear silazane, a monocyclic silazane, a polycyclic silazane, a polysilsesquiazane, a silatrane, a silquasilatrane, a silproatrane, an azasilatrane, an azasilquasiatrane, an azasilproatrane, or a combination of any two or more of these precursors;
in which the rate of erosion of the passivation layer or pH protective coating, if directly contacted by a fluid composition having a pH at some point between 5 and 9, is less than the rate of erosion of the barrier coating or layer, if directly contacted by the fluid composition.

### Claim 4

A vessel comprising:
a thermoplastic wall having an interior surface enclosing a lumen;
a fluid contained in the lumen having a pH greater than 5 disposed in the lumen;
a barrier coating or layer of SiOx, in which x is between 1.5 and 2.9, the barrier coating or layer applied by PECVD, positioned between the interior surface of the thermoplastic wall and the fluid, and supported by the thermoplastic wall, the barrier coating or layer having the characteristic of being subject to being measurably diminished in barrier improvement factor in less than six months as a result of attack by the fluid; and
a passivation layer or pH protective coating of SiOxCy, in which x is between 0.5 and 2.4 and y is between 0.6 and 3, the passivation layer or pH protective coating applied by PECVD, positioned between the barrier coating or layer and the fluid, and supported by the thermoplastic wall, the passivation layer or pH protective coating being effective to keep the barrier coating or layer at least substantially undissolved as a result of attack by the fluid for a period of at least six months.

### Claim 5 (depends on 1)

The filled package of claim 1, in which at least a portion of the wall of the vessel comprises or consists essentially of a polyolefin, a cyclic olefin polymer, a cyclic olefin copolymer, a polyester, a polycarbonate, polylactic acid, glass, or a combination or copolymer of these.

### Claim 6 (depends on 1)

The filled package of claim 1, in which the vessel comprises a syringe barrel, a cartridge, a vial, or a blister package.

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The filled package of claim 1, in which the barrier coating or layer is from 10 nm to 300 nm thick.

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12 (depends on 1)

The filled package of claim 1, in which the passivation layer or pH protective coating is applied by PECVD of a precursor feed comprising a linear siloxane, a linear silazane, a monocyclic siloxane, a polycyclic siloxane, a polysilsesquioxane, a monocyclic silazane, a polycyclic silazane, a polysilsesquiazane, a silatrane, a silquasilatrane, a silproatrane, an azasilatrane, an azasilquasiatrane, an azasilproatrane, or a combination of any two or more of these precursors.

### Claim 13

(canceled)

### Claim 14 (depends on 12)

The filled package of claim 12, in which the precursor feed further comprises an oxidizing gas.

### Claim 15 (depends on 14)

The filled package of claim 14, in which the precursor feed further comprises a noble gas.

### Claim 16 (depends on 15)

The filled package of claim 15, in which the precursor feed comprises:
from 0.5 to 10 standard volumes of an organosilicon precursor;
from 0.1 to 10 standard volumes of an oxidizing gas; and
from 1 to 100 sccm of a carrier gas.

### Claim 17 (depends on 1)

The filled package of claim 1, in which the passivation layer or pH protective coating as applied is between 100 and 700 nm thick.

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The filled package of claim 1, in which the rate of erosion of the passivation layer or pH protective coating, if directly contacted by a fluid composition having a pH of 8, is from 5% to 20%, of the rate of erosion of the barrier coating or layer, if directly contacted by the same fluid composition under the same conditions.

### Claim 20 (depends on 1)

The filled package of claim 1, in which the passivation layer or pH protective coating is at least coextensive with the barrier coating or layer.

### Claim 21 (depends on 1)

The filled package of claim 1, having a minimum shelf life, after the invention is assembled, of at least two years, wherein the shelf life is determined at 4° C.

### Claim at position 22

22-24. (canceled)

### Claim 25 (depends on 1)

The filled package of claim 1, in which the fluid composition removes the passivation layer or pH protective coating at a rate of 1 nm or less of passivation layer or pH protective coating thickness per 44 hours of contact.

### Claim 26 (depends on 1)

The filled package of claim 1, in which the passivation layer or pH protective coating is effective to provide a lower frictional resistance than the uncoated interior surface.

### Claim 27 (depends on 26)

The filled package of claim 26 wherein the frictional resistance is reduced by at least 45%, in comparison to the uncoated interior surface.

### Claim 28 (depends on 26)

The filled package of claim 26, in which the passivation layer or pH protective coating is effective to reduce the frictional resistance between a portion of the wall contacted by the fluid composition and a relatively sliding part after the invention is assembled, wherein the filled package is a syringe comprising a syringe barrel and the relatively sliding part, wherein the wall defines at least a portion of the syringe barrel and the relatively sliding part comprises a plunger tip, piston, stopper, or seal.

### Claim at position 27

29-32. (canceled)

### Claim 33 (depends on 1)

The filled package of claim 1, in which an FTIR absorbance spectrum of the passivation layer or pH protective coating has a ratio greater than 0.75 and at most 1.7, between:
the maximum amplitude of the Si—O—Si symmetrical stretch peak between about 1000 and 1040 cm-1, and
the maximum amplitude of the Si—O—Si assymmetric stretch peak between about 1060 and about 1100 cm−1.

### Claim 34

(canceled)

### Claim 35

(canceled)

### Claim 36 (depends on 1)

The filled package of claim 1, in which the silicon dissolution rate by a 50 mM potassium phosphate buffer diluted in water for injection, adjusted to pH 8 with concentrated nitric acid, and containing 0.2 wt. % polysorbate-80 surfactant from the vessel is less than 170 ppb/day.

### Claim 37 (depends on 1)

The filled package of claim 1, in which the total silicon content of the passivation layer or pH protective coating and barrier coating or layer, upon dissolution into 0.1 N potassium hydroxide aqueous solution at 40° C. from the vessel, is less than 66 ppm.

### Claim 38 (depends on 1)

The filled package of claim 1, in which the calculated shelf life (total Si/Si dissolution rate) is more than 2 years and less than 5 years.

### Claim at position 34

39-41. (canceled)

### Claim 42 (depends on 1)

The filled package of claim 1, in which the passivation layer or pH protective coating is applied by PECVD at a power level of from 1 to 250 W.

### Claim 43 (depends on 1)

The filled package of claim 1, in which the ratio of the electrode power to the plasma volume is from 6 W/ml to 60 W/ml.

### Claim at position 37

44-74. (canceled)
